bpc-157 current status fda approval 2026 Explained: Benefits, Safety & Oral vs Injectable Options Survey: Half of Peptide-Users Aren't

At the same time, immune system chemicals (cytokines) call in immune cells that attack the nerves, causing more injury

And critically some topical peptides actually have human clinical trial data

Compounded BPC-157 would be prepared by a licensed pharmacy under prescriber direction for a specific patient, an activity Health Canada has flagged as outside permissible scope for unauthorized injectable peptides in Canada (and one that was blocked in the United States during the Category 2 period from late 2023 to April 2026)

Caution is also advised in patients with conditions such as asthma, cardiac disease, renal impairment, migraine, or epilepsy, as HCG can lead to fluid retention that may worsen these conditions